28 Sep 2023 Interim Results
Posted at 07:00h
in Uncategorized
Company positioned for long-term sustainable growth following the acquisition of Yourgene Health
Paris, France and Eastleigh, UK – 28 September 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its unaudited interim results for the six months ended 30 June 2023.